MALVERN, Pa., March 19, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy ...

Every year, about 85,000 Americans are diagnosed with bladder cancer. While treatment is often successful, bladder cancer has one of the highest rates of recurrence of any cancer: Following treatment, ...

AMSTERDAM — Experts at HLTH Europe 2024 told conference participants that "digital biomarkers" are on the horizon. Industry experts explained at a session on June 19 that these relatively new ...

The new capital will accelerate the adoption of MEDiC’s breakthrough cancer biomarker discovery technology, bolster business development, and advance drug discovery efforts. “As cancer drug ...

NeuroDex is developing a blood-based biomarker research platform designed to study molecular signals associated with ...

Canary Speech, an AI-enabled voice biomarker technology company, was awarded a patent for the development of its paired neural networks for speech analysis, which is aimed at advancing the field of ...

Dr. Trisha Swift is the CEO of Mula, an integrative health practice specializing in tech enabled preventative care and root-cause healing. A recent study published in Current Biology has made waves in ...

Powering Precision Health 2022 Alzheimer’s podcast announced in recognition of Biomarker Factory launch “Researchers are exploring the utility of ultrasensitive plasma biomarkers for drug trial ...

Cardiovascular diseases remain the leading cause of death worldwide, accounting for nearly 20 million deaths each year. Rapid diagnosis and risk assessment of cardiac injury are therefore essential ...

A newly discovered Zika virus-specific synthetic molecule is capable of differentiating Zika-immune patient samples from samples of patients previously infected with the related dengue virus. The ...